Advent Takes 50% Stake In Biopharma Services Co. InVentiv
Advent International has agreed to make a sizable investment in inVentiv Health that values the biopharmaceutical services provider at around $3.8 billion, the private equity firm said Monday, a deal that...To view the full article, register now.
Already a subscriber? Click here to view full article